Invest In MJ Charts: Emerald Health Therapeutics (TSXV:EMH, OTC:EMHTF)

Emerald Health Therapeutics is a Health Canada Licensed Producer of medical cannabis. As one of the first licensees, we are pioneers in providing safe, efficacious, and clinically proven, high-value cannabis products that enhance the health of Canadians across the country. A vertically integrated, seed-to-sale enterprise, Emerald has combined core competencies from decades of experience in pharmaceutical development with expertise in large-scale greenhouse growing to become an emerging leader in the global cannabis industry.

Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals - Sept 19, 2017

Emerald’s multi-phase expansion plan is timed for massive scaling to meet anticipated demand from a legalized recreational cannabis market. Our multi-phase plan on a 32-acre site in Metro Vancouver includes modular expansion of our purpose-built growing facilities. Each phase is expected to contribute 50,000 sf of grow capacity, and each $10m in CAPEX is projected to yield 10,000 kg of production. We believe this model will create tremendous investment value, and plan to complete the first two phases of expansion prior to legalization, which would add a total 100,000 sf of grow capacity.

Invest In MJ Report Posted on Talk Markets: Overview Of Emerald Health Therapeutics, A Growing Cannabis Producer In Canada